The most recent media is served for Multiple Sclerosis
Going live – immune cell activation in multiple sclerosis 
HealthCanal.com Wed, 22 May 2013 14:53:19 -0700
Their findings provide new insight into the role of these cells in the autoimmune disease multiple sclerosis (MS). The new indicators are set to be an important tool in the study of other immune reactions as well. Inflammation is the body's defence ...
KVOA Tucson News Wed, 22 May 2013 09:30:08 -0700
But what is even more impressive about Whitaker is that he participated in all of those activities after being diagnosed with Multiple Sclerosis. "I woke up on the second day of my senior year and my hand was numb," Whitaker says. He was devastated.Motley Fool Tue, 21 May 2013 16:52:40 -0700
In this video, health-care analyst David Williamson discusses Biogen's latest drug up for FDA approval. The big biotech is on a roll lately: The FDA recently accepted applications for two hemophelia drugs and today came news of multiple sclerosis drug ...
Motley Fool
Tue, 21 May 2013 16:52:40 -0700
In this video, health-care analyst David Williamson discusses Biogen's latest drug up for FDA approval. The big biotech is on a roll lately: The FDA recently accepted applications for two hemophelia drugs and today came news of multiple sclerosis drug ...Vail Daily News
Beaver Creek's support validates all the hard work we're doing in our community to raise awareness of multiple sclerosis and to provide programs and education to people living with MS.” said Heidi A. Heltzel, president and CEO of Can Do MS ... Yahoo! News
(Reuters) - XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in 2015 after a late-stage trial failed to show significant improvement over a placebo. Shares of the company fell 26 percent ... Reuters
May 20 (Reuters) - XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition significantly compared with a placebo. Shares of the ...The Daily Advertiser
Fort Mills Times
Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease ...Updated 7 minutes ago
Trending Top 15
Tweet / Like this trend!